Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 39 for “"HCV genotype"”.
-
Implications of HCV genotype 3 specific immunity on cross-reactive vaccine design
<p>Hepatitis C virus (HCV) is a major global pathogen that infects an estimated 170 million people worldwide, and for which currently no vaccine is available. HCV is a highly diverse viral pathogen and exists as 6 major genotypes sharing only 75% sequence homology; developing a vaccine that is …
-
Development of tools to investigate resistance of HCV genotype 3 to NS5A inhibitors
HCV infection leads to liver failure. Genotype 3 (GT3) is known to respond poorly to newly-developed direct-acting antivirals, especially inhibitors of the multifunctional NS5A protein. This work reports the establishment of efficient transient replication of the S52 GT3 sub-genomic replicon (SGR) …
-
HOST GENETIC INFLUENCE ON HIV AND HCV INFECTIONS
… with chronic hepatitis C, the hepatitis C virus (HCV) RNA level is an important predictor of treatment response. To explore the relationship of HCV RNA with viral and demographic factors, as well as IL28B genotype, we examined viral levels in an ethnically diverse group of injection drug users …
-
Development of Cell Culture Replication Systems for Hepatitis Rirus Genotype 5A
The hepatitis C virus (HCV) infection is a major cause of chronic hepatitis, liver cirrhosis, and hepatocellular carcinoma with an estimated 170 million people chronically infected with the virus. Among the genotypes of HCV, genotype 5a (GT 5a) was first identified in a cohort of South African …
-
Translational genomics, transcriptomics and metabolomics analyses of the metabolic effects of chronic hepatitis C infection and their clinical implications
Background: The hepatitis C virus (HCV) relies on host lipid pathways for its life cycle, leading to metabolic consequences including hypocholesterolemia, insulin resistance and hepatic steatosis. These sequelae have varying clinical implications, including poorer sustained viral response (SVR) to …
-
The interaction of hepatitis C virus and intracellular lipid metabolism
Chronic hepatitis C virus (HCV) infection causes inflammation of the liver, which can lead to fibrosis and cirrhosis over time. Whether liver damage is a consequence of viral infection or is due to an immune mediated response is not clear. Steatosis is a histopathological feature often found in HCV …
-
Diagnosis and natural history of acute hepatitis C virus infection
… understanding of natural history of acute HCV infection provides insights into immunopathogenesis, have implications for vaccine research and guides early treatment. Aims: The broad aim of this research was to inform diagnosis and natural history of acute HCV infection. Specific aims …
-
STRUCTURAL BASIS FOR ANCHORING HCV REPLICATION COMPLEX ONTO THE HUMAN ER-MEMBRANE: IMPLICATIONS FOR HCV-TRIGGERED ALS PATHOGENESIS
Hepatitis C virus (HCV) affects nearly 200 million people worldwide and is a leading factor for serious chronic liver diseases. Replication of HCV genome occurs on membrane associated replication complex, which is formed by the interaction of HCV non-structural proteins including NS5A and NS5B, and …
-
Characterisation of the translation efficiency and quasispecies composition of the 5'untranslated region of Hepatitis C virus in genotype 1 and 3 infected patients
Hepatitis C virus (HCV) infects over 170 million people worldwide. Chronic infection occurs in 50-80% of cases and eventually leads to cirrhosis and hepatocellular carcinoma. HCV can be classified into six genotypes. Genotypes 1, 2 and 3 have a world-wide distribution but their prevalence differs …
-
INFLUENZA DEI POLIMORFISMI DI IL-28B E SLC29A1 SULLA RISPOSTA ALLA TERAPIA CON INTERFERONE PEGILATO E RIBAVIRINA IN PAZIENTI COINFETTI HIV-HCV
HCV coinfection is the major health complication for HIV patients. More frequently than some years ago their death is related to HCV induced end-stage liver disease rather than AIDS induced by HIV. The reason for this is the significant progress in development of antiretroviral therapy allowing HIV …
-
L'IMPATTO DEL POLIMORFISMO GENETICO IL 28B SUL TRATTAMENTO ANTIVIRALE CON INTERFERONE PEGHILATO E RIBAVIRINA IN PAZIENTI CON EPATITE CRONICA C GENOTIPO 4
… (Rbv) in patients with hepatitis C virus (HCV) genotype 1 infection. Whether this holds true for HCV-4 patients too, is unknown. Aim To investigate the predictive power of the rs12979860 IL28B SNP for a response to Peg-IFN and Rbv in HCV-4 patients. Methods. All HCV-4 patients consecutively …
-
Drug resistance mechanisms and drug design strategies for human immunodeficiency virus and hepatitis c virus proteases
… virus (HIV) and hepatitis C virus (HCV) which represent heavy public health burdens. The viral protease plays an indispensable role in viral maturation and therefore becomes one of the most important targets for drug design. Nine HIV-1 protease inhibitors and two HCV protease …
-
Lebertransplantation bei Hepatitis-C-assoziiertem Endstadium der Lebererkrankung
… regarding demographics, inflammation, fibrosis, HCV-genotyp, antiviral treatment, retransplantation, HCV-recurrence and survival. Results: Significant improvement in the therapeutic success of the antiviral therapy (p < 0.01) of the interferon-free treatment regimens over previous treatment …
-
Επιδημιολογικά - ιολογικά χαρακτηριστικά και αποτελεσματικότητα της αγωγής σε χρήστες τοξικών ουσιών με χρόνια ηπατίτιδα C
Introduction: The prevalence of HCV infection is estimated at > 185 million worldwide, and undiagnosed infections can increase this prevalence by 20-30%. Aim: To evaluate a) HCV genotype distribution in chronic HCV-infected patients and b) the sustained virological response (SVR), at least 24 weeks …
-
Κλωνοποίηση, έκφραση και διερεύνηση των ανοσοβιολογικών ιδιοτήτων των πρωτεϊνών core/core+1 του ιού της ηπατίτιδας C
Hepatitis C virus (HCV) is a member of Ηepacivirus genus within the Flaviviridae family. It infects the human liver and is a major cause of acute and chronic hepatitis, which in turn leads to severe liver diseases, such as chronic active hepatitis, cirrhosis, and hepatocellular carcinoma (HCC). An …
-
Ποιότητα ζωής σε ασθενείς με χρόνια ηπατίτιδα C - επίδραση της θεραπείας με ιντερφερόνη
… carcinoma and death. Furthermore although HCV infection has been thought to be an asymptomatic disease, it is now understood that it can cause a series of neuropsychiatric symptoms prior to liver cirrhosis. On the other hand, the currently approved treatment for chronic hepatitis C can …
-
Highly active anti-retroviral therapy and liver mitochondrial toxicity in human immunodeficiency virus / hepatitis C virus co-infection
… of HIV-infected patients are co-infected with HCV in the developed world, and more of co-infected patients than ever before are dying because of liver related diseases today. Drug-related hepatotoxicity is a growing concern among human immunodeficiency virus (HIV) / hepatitis C virus (HCV) …
-
Investigating hepatitis C transmission dynamics and disease implications in Sindh province, Pakistan: a statistical and mathematical modelling
… Hepatitis B Virus (HBV) and Hepatitis C Virus (HCV) infection by 2030. Pakistan has the highest number of individuals with HCV infections globally. Understanding the evolving epidemiology of HBV and HCV is essential for tracking progress and guiding elimination efforts in Pakistan. <br/>First, I …
-
Μελέτη έκκρισης κυτταροκινών κυτταρικής και χυμικής ανοσίας σε παιδιά και εφήβους με χρόνια ηπατίτιδα C
… Contrary to adults, the immunopathogenesis of HCV infection has not been studied enough in chlidren. The purpose of this study was to describe the immune response to HCV infection, (Th1 and Th2 immune responses) via measuring cytokine excretion of cultured peripheral blood monocytes, after …
-
The Role of Interferon Stimlated Genes in Resistance and Immunity to Hepatitis C Virus Infection
Hepatitis C Virus (HCV) is a global public health issue with 170 million people chronically infected. The only approved treatment for HCV infection is interferon-alpha based therapy, resulting in viral clearance in approximately fifty percent of patients treated. Interferon therapy mimics …
Page 1 of 2